2000
DOI: 10.1016/s0014-2999(00)00866-9
|View full text |Cite
|
Sign up to set email alerts
|

A novel anti-rheumatic drug suppresses tumor necrosis factor-α and augments interleukin-10 in adjuvant arthritic rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
16
0

Year Published

2001
2001
2012
2012

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(19 citation statements)
references
References 14 publications
3
16
0
Order By: Relevance
“…Indeed, LPS-induced cytokines production in adjuvant arthritis rats are augmented in comparison with normal rats [12]. In the present study, both daily and single administration of BLF suppressed TNF-α production and increased IL-10 production in the LPS-stimulated adjuvant arthritis rats (Fig.…”
Section: Discussionsupporting
confidence: 55%
“…Indeed, LPS-induced cytokines production in adjuvant arthritis rats are augmented in comparison with normal rats [12]. In the present study, both daily and single administration of BLF suppressed TNF-α production and increased IL-10 production in the LPS-stimulated adjuvant arthritis rats (Fig.…”
Section: Discussionsupporting
confidence: 55%
“…IL-4 and IL-10 (Th2 anti-inflammatory cytokines) have been thought to be upstream regulators that control the progression of RA negatively. IL-4 enhances the synthesis and the production of tissue inhibitors of MMPs in human mononuclear phagocytes and cartilage explants, and hence suppresses MMPs activation, while IL-10 inhibits the cytokine production and release by activated macrophages [34,35]. In the present study, all changes in pro-inflammatory and anti-inflammatory cytokines of arthritic rats were completely prevented in arthritic rats that received TRPS only (Fig.…”
Section: Discussionsupporting
confidence: 53%
“…For instance, a novel recent study by Haskó et al (23) reported a potential role for extracellular purines, including adenosine and ATP, and inosine, a degradation product of these purines, as potent endogenous immunomodulatory molecules that inhibit inflammatory cytokine biosynthesis and protect against endotoxin-induced shock. It has also been reported, in addition, that selective inhibition of phosphodiesterases, a family of enzymes involved in the degradation of cAMP (24,25), steroids, such as glucocorticoids (26), pyrimidylpiperazine derivatives (19,(27)(28)(29), and ERK and p38/RK MAPK selective inhibitors (30,31) differentially regulate the transcription and biosynthesis of inflammatory cytokines. The promoters of genes encoding cytokines contain multiple cis-acting motifs including those that bind such transcription factors as NF-B.…”
Section: Vol 285 No 2 2001mentioning
confidence: 99%